Additionally, advanced CRC has been correlated with the immunomodulatory protein TcpC, known to counter the host’s innate immune defense by abrogating the function of MyD88 in macrophages that further impairs the involved signaling processes [30]. Here, MYD88 is linked to colorectal carcinoma.